Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Azithromycin Impurity 8

● Under Development

Katalog-Nr.::	VL1860022
CAS-Nr.::	N/A
Summenformel::	C36H65NO12
Molare Masse::	703.91 g/mol

Wie können wir helfen?

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Azithromycin Impurity 8

Parent drug

Azithromycin

IUPAC-Name

(2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-2-ethyl-3, 4, 10-trihydroxy-13-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2S, 3R, 6R)-3-hydroxy-6-methyl-3, 6-dihydro-2H-pyran-2-yl)oxy)-3, 5, 6, 8, 10, 12, 14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one

Synonyme

N/A

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Beschreibung

It is an impurity of Azithromycin. Azithromycin is employed to treat sure microorganism infections, like bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and procreative organs. Azithromycin is also wont to treat or forestall disseminated true bacteria avium advanced (MAC) infection.